Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study

BACKGROUND: Few studies have examined chemotherapy-induced peripheral neuropathy (CIPN) following the administration of eribulin as first- or second-line therapy in patients with breast cancer. We therefore assessed CIPN incidence by severity and risk factors for CIPN in patients treated with eribul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsurutani, Junji, Sakata, Yukinori, Matsuoka, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394617/
https://www.ncbi.nlm.nih.gov/pubmed/30324551
http://dx.doi.org/10.1007/s12282-018-0919-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394617/
https://www.ncbi.nlm.nih.gov/pubmed/30324551
http://dx.doi.org/10.1007/s12282-018-0919-8

Ejemplares similares